1-6 of 6
Rony Abou-Jawde
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment Patterns and Predictors of Survival after First Line Therapy in Large B-Cell Lymphoma in a Real-World US Cohort

Joseph P. McGuirk, Mark Fesen, Scott D. Ramsey, Rony Abou-Jawde, Anthony Proli, Hil Hsu, Anik R Patel, Miguel-Angel Perales, Blythe Adamson, Jiarui Fu, Jeremy Snider
Journal: Blood
Blood (2024) 144 (Supplement 1): 2367.
https://doi.org/10.1182/blood-2024-208283
Published: 2024
Journal Articles

Impact of Socioeconomic Status and Distance from Treatment Center on Survival in Patients Receiving Remission Induction Therapy for Newly Diagnosed Acute Myelogenous Leukemia (AML).

Cristina Rodriguez, Rachid Baz, Rony Abou Jawde, Lisa Rybicki, Christopher Lowe, Matt Kalaycio, Anjali Advani, Ronald Sobecks, Mikkael A. Sekeres
Journal: Blood
Blood (2006) 108 (11): 1920.
https://doi.org/10.1182/blood.V108.11.1920.1920
Published: 2006
Journal Articles

Prognostic Factors and Outcomes of Patients with Acute Myeloid Leukemia (AML) Receiving Non Intensive Chemotherapy (NIC) or Best Supportive Care (BSC).

Rachid Baz, Cristina Rodriguez, Rony Abou Jawde, Lisa Rybicki, Matt Kalaycio, Anjali Advani, Ronald Sobecks, Mikkael A. Sekeres
Journal: Blood
Blood (2006) 108 (11): 4492.
https://doi.org/10.1182/blood.V108.11.4492.4492
Published: 2006
Journal Articles

c-Kit (CD117) Expression Is a Poor Prognostic Factor for Relapse and Overall Survival in Patients with Newly Diagnosed AML.

Cristina Rodriguez, MD, Tao Jin, MS, Rony Abou Jawde, MD, Wael Saber, MD, Rachid Baz, MD, Eric His, MD, Matt Kalaycio, MD, Ronald Sobecks, MD, Mikkael Sekeres, MD, Anjali Advani, MD
Journal: Blood
Blood (2006) 108 (11): 4510.
https://doi.org/10.1182/blood.V108.11.4510.4510
Published: 2006
Journal Articles

CD117 Expression Is a Poor Prognostic Factor (PF) for Progression Free Survival (PFS) and Freedom from Progression (FFP) in Patients with Newly Diagnosed Acute Myelogenous Leukemia (AML).

Wael Saber, MD, Rony Abou-Jawde, MD, Eric Hsi, MD, Tao Jin, MS, Matt Kalaycio, MD, Ronald Sobecks, MD, Mikkael Sekeres, MD, Brad Pohlman, MD, Barbara L. Tripp, RN, Anjali Advani, MD
Journal: Blood
Blood (2005) 106 (11): 3292.
https://doi.org/10.1182/blood.V106.11.3292.3292
Published: 2005
Journal Articles

Doxil (D), Vincristine (V), Reduced Frequency Dexamethasone (d) and Revlimid(R) (DVd-R) Results in a High Response Rate in Patients with Refractory Multiple Myeloma (RMM).

Rachid Baz, MD, Toni K. Choueiri, MD, Rony Abou Jawde, MD, Bridget McGowan, Yvette Ellis, Catherine Brand, Mohamad A. Hussein, MD
Journal: Blood
Blood (2005) 106 (11): 2559.
https://doi.org/10.1182/blood.V106.11.2559.2559
Published: 2005